E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 357.8 INR 1.83%
Market Cap: 256.8B INR
Have any thoughts about
Emcure Pharmaceuticals Ltd?
Write Note

Emcure Pharmaceuticals Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Emcure Pharmaceuticals Ltd
Total Receivables Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
E
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Total Receivables
â‚ą21.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Receivables
â‚ą80.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Receivables
â‚ą55.9B
CAGR 3-Years
17%
CAGR 5-Years
7%
CAGR 10-Years
9%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Receivables
â‚ą129.9B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
10%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Receivables
â‚ą17.9B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
3%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Receivables
â‚ą9.4B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Emcure Pharmaceuticals Ltd's Total Receivables?
Total Receivables
21.1B INR

Based on the financial report for Mar 31, 2024, Emcure Pharmaceuticals Ltd's Total Receivables amounts to 21.1B INR.

What is Emcure Pharmaceuticals Ltd's Total Receivables growth rate?
Total Receivables CAGR 1Y
11%

Over the last year, the Total Receivables growth was 11%.

Back to Top